Natera, Inc. Common Stock (NTRA)
SERVICES-MEDICAL LABORATORIES
Natera, Inc. Common Stock (NTRA) is listed on Nasdaq, where it has traded since July 2, 2015.
- Listed On
- Nasdaq
- Listed Since
- July 2, 2015
- Employees
- 6,140
- Market Cap
- $57.3B
About Natera, Inc. Common Stock
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 830 institutions reported holding NTRA, with 136.4 million shares worth $37.0 billion in aggregate. The largest reported holder was Vanguard, with 13.3 million shares worth $3.6 billion. Of the 5 largest holders listed below, 3 added shares and 2 reduced their positions during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Vanguard | 13,344,472 | $3.6B | Added 3.44% |
| JPMorgan Chase | 12,865,346 | $3.5B | Reduced 3.89% |
| BlackRock | 10,914,608 | $3.0B | Added 2.22% |
| T. Rowe Price | 10,145,636 | $2.8B | Reduced 23.81% |
| FMR | 5,451,396 | $1.5B | Added 113.42% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is NTRA?
Natera, Inc. Common Stock (NTRA) is listed on Nasdaq, where it has traded since July 2, 2015.
Who are the largest institutional holders of NTRA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of NTRA were Vanguard, JPMorgan Chase and BlackRock.
How many institutions own NTRA?
830 institutions reported a position in NTRA for the quarter ended June 30, 2026, worth $37.0 billion in total.
Did institutions buy or sell NTRA last quarter?
Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for NTRA.
Every reported institutional holder, plus insider and congressional trades in NTRA, on SentiSense.